中文别名 |
(S)-N-缩水甘油邻苯二甲酰亚胺;(S)-N-环氧丙基邻苯二甲酰亚胺;(S)-(+)-N-(2,3-乙氧基丙基)邻苯二甲酰亚胺;利伐沙班中间体2;(S)-(+)-N-(2,3-乙氧基丙基)邻苯二甲酰亚胺,,利伐沙班中间体;(S)-(+)-N-(2,3-环氧丙基)邻苯二甲酰亚胺;S-(+)-N-(2,3-环氧丙基)邻苯二甲酰亚胺;(S)-N-Glycidylphthalimide (S)-N-环氧丙基邻苯二甲酰亚胺;(S)-N-缩0水甘油邻苯二甲酰亚胺;(S)-N-缩水甘油邻苯二甲酰亚胺原药;4,4'-联苯二腈基;4,4-联苯二腈基;N-(2,3-环氧丙基)邻苯二甲酰亚胺;S-邻苯二甲酰亚胺缩水甘油;利伐沙班中间体;(S)-N-(2,3-环氧丙基)邻苯二甲酰亚胺;(S)-N-缩水甘油邻苯二甲酰亚胺标准品;(S)-N-环氧丙基邻苯二甲酰亚胺, EE;S-邻苯二甲酰亚胺缩水甘油(利伐沙班中间体);(S)-(+)-N-(2,3-环氧丙基)邻苯;(S)-N-缩水甘油邻苯二甲酰亚胺 5G |
英文别名 |
(S)-N-Glycidylphthalimide;(S)-2-OXIRANYLMETHYL-ISOINDOLE-1,3-DIONE;(S)-GLYCIDYL PHTHALIMIDE;2-((2S)-OXIRANYLMETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE;(S)-(+)-N-(2,3-Epoxypropyl)phthalimide;2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione;Rivaroxaban Intermediate 2;S-(+)-N-(2,3-Epoxypropyl)phthalimide;(S)-(+)-GLYCIDYL PHTHALIMIDE;(S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione;(S)-N-(2,3-Epoxypropyl)phthalimide;1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole;2-[(2S)-oxiran-2ylmethyl]-1H-isoindole-1,3(2H)-dione;N-(S)-Glycidylphthalimide;1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2-oxiranylmethyl]-;2-(S)-1-oxiranylmethylisoindole-1,3-dione;2-[(2S)-2-oxiranylmethyl]-1H-isoindole-1,3(2H)-dione;2-[(2S)-oxiran-2ylmethyl]-1H-isoindole-1,3(2;671606_ALDRICH;AC1LEX2B;ISO076;PubChem21402;Rivaroxaban Impurity 39;(S)-(+)-GLYCIDYL PHTHALIdime;2-[(2S)-ox;(S)-N-GlycidylphthaliMide, ee: 98%;(S)-N-GlycidylphthaliMide, ee: 97.5%;1H-Isoindole-1,3(2H)-dione, 2-[(2S)-oxiranylmethyl]-;N-[(S)-Glycidyl]phthalimide;(S)-( )-Glycidyl Phthalimide;N-(;2-[[(2S)-oxiran-2-yl]methyl]isoindole-1,3-dione;T56 BVNVJ C1- BT3OTJ &&S Form;(S)-(+)-GlycidylPhthalimide;(S)-(+)-N-(2,3-Epoxypropyl)phthalimide/(S)-N-Glycidylphthalimide;GS-3726;UNII-WWD33Z178Q |